Literature DB >> 33521206

Rapid Recovery Is Feasible for Aseptic Revision Total Knee Arthroplasty at an Academic Medical Center.

Josef Pontasch1, Mario Sahlani1, Sumon Nandi2.   

Abstract

BACKGROUND: We reviewed the results of a primary total knee arthroplasty (TKA) rapid recovery care pathway applied to patients undergoing aseptic revision TKA. We sought to determine (1) the frequency of postoperative day (POD) 1 discharge, (2) the risk of adverse events, and (3) patient characteristics or surgical factors associated with failure to discharge on POD 1.
METHODS: The source population was revision TKAs performed by a single surgeon at an academic medical center from 2016 to 2019 (n = 94). A primary TKA rapid recovery care pathway was applied to all patients who underwent aseptic revision TKA involving both femoral and tibial components (n = 33). Patients discharged on POD 1 (n = 21) were compared with those discharged on POD 2 or later (n = 12).
RESULTS: The study cohort was 70% women, 12% under-represented minorities, and 70% government insured. Patients each had an average of 5 comorbidities. The average length of stay was 1.7 days, with 64% of patients discharged on POD 1. Ninety-seven percent of patients were discharged home. Although 18% of patients presented to the emergency room (ER) after discharge, there was no increased risk of readmission (P = .9336) or return to the ER (P = .9849) with POD 1 discharge. The LOS was unaffected by patient characteristics or complexity of surgical reconstruction.
CONCLUSIONS: Using a rapid recovery care pathway for aseptic revision TKA is feasible at an academic medical center. All patients may be considered for this pathway. Close postoperative monitoring is essential to minimizing ER visits, which are not uncommon.

Entities:  

Keywords:  Knee; Length of stay; Rapid recovery; Revision; Total knee arthroplasty

Year:  2021        PMID: 33521206      PMCID: PMC7818602          DOI: 10.1016/j.artd.2020.11.001

Source DB:  PubMed          Journal:  Arthroplast Today        ISSN: 2352-3441


Introduction

The frequency of revision total knee arthroplasty (TKA) is increasing at a rate even faster than that of primary TKA [1]. Revision TKA has higher associated morbidity and uses more expensive implants than primary TKA [2,3]. As a result, efforts to decrease the cost of revision TKA to both patients and the health-care system are imperative. Enhanced recovery after surgery, or rapid recovery, is a practice consisting of multimodal interventions designed to improve the quality and speed of recovery while decreasing costs associated with prolonged hospital length of stay (LOS) [4,5]. Preoperatively, rapid recovery is comprised of robust patient education, nonopiate preemptive analgesia, and efforts to prevent postoperative nausea and vomiting. Intraoperatively, regional anesthesia and local anesthesia are used, as are blood conservation measures. Postoperatively, patients are mobilized immediately as they begin their rehabilitation. Rapid recovery care pathways safely decrease LOS and allow home discharge after primary TKA [6,7]. Shorter LOS decreases the risk of venous thromboembolism [8]. Home discharge minimizes the risk of adverse events and readmission associated with rehabilitation facility discharge [9]. Thus, rapid recovery increases quality of care while decreasing episode of care cost. Revision TKA is a surgery more extensive and of longer duration than that of primary TKA. It is unknown if rapid recovery care pathways may be effectively applied to revision TKA to decrease morbidity and cost, although we hypothesize rapid recovery revision TKA is feasible. To this end, we reviewed the results of a primary TKA rapid recovery care pathway applied to patients undergoing aseptic revision TKA. The aim of this study was to determine (1) the frequency of successful postoperative day (POD) 1 discharge, (2) the risk of adverse events, if any, and (3) patient characteristics or surgical factors associated with failure to discharge on POD 1.

Material and methods

Study design

A retrospective cohort study design approved by our institutional review board was used in this study. Our source population was all revision TKAs performed by a single adult reconstruction fellowship-trained surgeon at an academic orthopaedic tertiary referral center from 2016 to 2019 (n = 94). Inclusion criterion was aseptic revision TKA involving both femoral and tibial components. Exclusion criteria were two-stage revision TKA (explant or reimplantation), TKA irrigation and debridement with polyethylene liner exchange, other single-component revision TKA, or less than 90-day follow-up. This yielded a study cohort of 33 revision TKAs. All surgeries were performed using a single-design, varus and valgus constrained prosthesis (Triathlon Total Stabilizer, Stryker, Mahwah, NJ) with stemmed femoral and tibial components. Augments and metaphyseal cones were implanted as needed. A rapid recovery care pathway used for primary TKA was applied to all patients who underwent revision TKA in the study cohort. A total joint replacement nurse coordinator performed one-on-one preoperative patient education and provided corresponding written material. The focus of these encounters was postoperative rehabilitation, wound care, as well as assessment and optimization of patients’ home environment including social support. Both the surgeon and nurse coordinator advised patients preoperatively they would ambulate the same day of surgery and be discharged home the following day by 11 am. Surgery was scheduled on a date that allowed friends or family to stay at home with the patient for 1 week afterward. Prescriptions for durable medical equipment, including rolling walker, shower chair, and raised toilet seat, were given to patients before surgery. Multimodal pain management consisted of preoperative oral administration of 400 mg of celecoxib, 300 mg of gabapentin, and 1000 mg of acetaminophen; intraoperatively, 60 cc of 0.25% bupivacaine with epinephrine was injected into the periarticular tissues; postoperatively, hydrocodone and acetaminophen 5 mg/325 mg, 1 to 2 tablets orally every 4 hours as needed was prescribed. Patients received an adductor canal nerve block in the preoperative holding area, 10 mg of intravenous (IV) dexamethasone and 1 g of IV tranexamic acid during induction of general anesthesia, followed by another 1 g of IV tranexamic acid during wound closure. Foley catheter was removed in the operating room before transfer to the postanesthesia care unit. Day-of-surgery postoperative ambulation was performed with the assistance of physical therapy, nursing, or the surgical team. Hospital discharge occurred only if patients were medically stable and cleared by physical and occupational therapy. Patients successfully discharged on POD 1 (n = 21) were compared with those discharged on POD 2 or later (n = 12). Patient demographics, comorbidities, preoperative Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, Jr.), implants, LOS, discharge disposition, readmission or reoperation for any reason, and emergency room (ER) visits were recorded on a standard data collection form after systematic chart review. The LOS was determined by the POD of discharge and hours of hospitalization from post–anesthesia care unit admission to discharge.

Statistical analysis

Baseline demographic and clinical characteristics were compared between patients discharged on POD 1 and those discharged on POD 2 or later. Fisher’s exact test was used to compare categorical variables, and the Wilcoxon test was used to compare continuous variables. The primary outcome of this study was POD 1 discharge. Secondary outcomes included discharge location, complications, and 90-day readmission or ER visit. We used stepwise logistic regression to identify the proper predictors of POD 1 discharge and secondary outcomes. Potential predictors, including age, gender, body mass index, smoking status, comorbidities, insurance type, preoperative KOOS, Jr. score, the number of femoral augments, the number of tibial augments, and the use of tibial cone had to achieve a significance level of P = .1 to enter the model and remain in the final model. The power to detect a 50% absolute difference in the percent of patients requiring ER visits and readmissions between those discharged on POD 1 or later was 0.83.

Results

Univariate analysis of baseline demographics for patients successfully discharged on POD 1 vs those discharged on POD 2 or later is given in Table 1. Seventy percent of our study patients were women, 12% were under-represented minorities, and 70% had government insurance. Each patient had an average of 5 comorbidities.
Table 1

Univariate analysis of baseline patient characteristics between patients who underwent revision TKA discharged on POD 1 or later.

VariablePOD 1 discharge (N = 21)POD 2 or later discharge (N = 12)P-value
Age (mean, SD)64.9 (8.7)68.3 (12.9).6153
BMI (kg/m2) (mean, SD)35.2 (5.4)33.7 (8.3).6430
Number of comorbidities (mean, SD)5 (1.9)5 (2.7).8503
Gender.7098
 Female14 (66.7%)9 (75%)
 Male7 (33.3%)3 (25%)
Insurance type.1022
 Medicare9 (42.9%)8 (66.7%)
 Medicaid9 (42.9%)3 (25%)
 Private3 (14.3%)1 (8.3%)
Preoperative KOOS, Jr. score.6382
 Missing8 (38.1%)4 (33.3%)
 20 (0%)1 (8.3%)
 70 (0%)1 (8.3%)
 91 (4.8%)0 (0%)
 101 (4.8%)0 (0%)
 141 (4.8%)0 (0%)
 152 (9.5%)0 (0%)
 182 (9.5%)2 (16.7%)
 191 (4.8%)1 (8.3%)
 201 (4.8%)1 (8.3%)
 211 (4.8%)0 (0%)
 220 (0%)1 (8.3%)
 252 (9.5%)0 (0%)
 261 (4.8%)1 (8.3%)
Atrial fibrillation0 (0%)2 (16.7%).125
Anxiety4 (19%)4 (33.3%).4196
Cardiac arrhythmia1 (4.8%)1 (8.3%)1
Asthma4 (19%)2 (16.7%)1
Bipolar disorder2 (9.5%)0 (0%).5227
Cancer2 (9.5%)3 (25%).3275
Coronary artery disease1 (4.8%)0 (0%)1
COPD6 (28.6%)2 (16.7%).6776
Dementia1 (4.8%)0 (0%)1
Depression12 (57.1%)8 (66.7%).7188
Diabetes6 (28.6%)3 (25%)1
History of DVT1 (4.8%)2 (16.7%).5381
GERD9 (42.9%)4 (33.3%).7188
Hypercholesterolemia12 (57.1%)7 (58.3%)1
Heart failure1 (4.8%)2 (16.7%).5381
Hyperlipidemia1 (4.8%)0 (0%)1
Hypertension15 (71.4%)7 (58.3%).4713
Number of femoral augments.2868
 05 (23.8%)3 (25%)
 12 (9.5%)1 (8.3%)
 24 (19%)5 (41.7%)
 34 (19%)3 (25%)
 46 (28.6%)0 (0%)
Number of tibial augments.6741
 016 (76.2%)10 (83.3%)
 11 (4.8%)1 (8.3%)
 24 (19%)1 (8.3%)
Use of tibial cone5 (23.8%)1 (8.3%).3729

BMI, body mass index; COPD, chronic obstructive pulmonary disease; DVT, deep venous thrombosis; GERD, gastroesophageal reflux disease; SD, standard deviation.

P < .05 considered significant.

Univariate analysis of baseline patient characteristics between patients who underwent revision TKA discharged on POD 1 or later. BMI, body mass index; COPD, chronic obstructive pulmonary disease; DVT, deep venous thrombosis; GERD, gastroesophageal reflux disease; SD, standard deviation. P < .05 considered significant. Table 2 shows unadjusted outcome comparisons between groups. The average LOS for all patients was 1.7 days. Sixty-four percent of patients were discharged on POD 1, 24% of patients were discharged on POD 2, and 12% of patients were discharged on POD 3 or later. The mean duration of admission was 22 hours for patients discharged on POD 1 and 43 hours for patients discharged on POD 2. Only 1 (3.0%) patient required discharge to a skilled nursing facility, whereas all others were discharged home.
Table 2

Univariate analysis of outcomes between patients who underwent revision TKA discharged on POD 1 or later.

VariablePOD 1 dischargePOD 2 or later dischargeP-value
Discharge location.3636
 Rehabilitation facility0 (0%)1 (8.3%)
 Home21 (100%)11 (91.7%)
Reoperation1 (4.8%)0 (0%)1
90-day readmission2 (9.5%)0 (0%).5227
90-day ER visit4 (19.0%)2 (16.7%)1
Delayed wound healing0 (0%)0 (0%)NA
Other complications0 (0%)0 (0%)NA

P < .05 considered significant.

Univariate analysis of outcomes between patients who underwent revision TKA discharged on POD 1 or later. P < .05 considered significant. Although 18% of all patients presented to the ER after discharge, multivariate analysis demonstrated no increased risk of readmission (P = .9336) or return to the ER (P = .9849) with POD 1 discharge (Table 3). Neither insurance status nor the use of augments or cones was associated with readmissions or ER visits. Reasons for return to the hospital within 90 days of revision TKA are outlined in Table 4.
Table 3

Multivariate analysis of risk of 90-day (A) readmission or (B) ER visit after TKA revision.

A. Readmissions
VariableOdds ratio point estimate95% Wald confidence limitsP-value
POD 1 versus later discharge0.8650.02926.152.9336
Insurance (Medicaid vs. private)2.5870.049136.044.4069
Insurance (Medicare vs. private)0.2140.00510.210.3226
Number of femoral and tibial augments2.0610.7435.714.1645
Tibial cone (yes vs. no)18.1590.631522.276.0907

P < .05 considered significant.

Table 4

Return to hospital within 90 days of revision TKA.

VariableLOS after revision TKAER visitReadmissionHospital return POD#Reason for return to the hospital
Patient 13 daysX6Supratherapeutic INR
Patient 22 daysX7Pain at the operative site
Patient 31 dayX14Pain at the operative site
Patient 41 dayX7Pain at the operative site
Patient 51 dayX7Wound check (unremarkable)
Patient 61 dayX14Upper respiratory infection
Patient 71 dayX76Traumatic arthrotomy and patellar tendon laceration requiring reoperation
Patient 81 dayX4Altered mental status from dehydration and hypoglycemia
Multivariate analysis of risk of 90-day (A) readmission or (B) ER visit after TKA revision. P < .05 considered significant. Return to hospital within 90 days of revision TKA. No patient characteristics, including age, gender, body mass index, insurance status, comorbidities, or preoperative KOOS, Jr., were predictive of the LOS based on multivariate analysis. The LOS was unaffected by the use of augments (P = .5292) or cones (P = .7195) (Table 5).
Table 5

Multivariate analysis of likelihood of POD 1 discharge after TKA revision.

VariableOdds ratio point estimate95% Wald confidence limitsP-value
Age0.9940.9091.088.8993
Insurance (Medicaid vs. Medicare)0.2480.0222.836.4962
Insurance (private vs. Medicare)0.2530.0272.354.4754
Number of femoral and tibial augments1.1700.7181.907.5292
Use of tibial cone1.4940.16713.386.7195

P < .05 considered significant.

Multivariate analysis of likelihood of POD 1 discharge after TKA revision. P < .05 considered significant.

Discussion

Aseptic revision TKA requires techniques to restore ligament balance and bone loss. More costly stemmed implants, with or without augments, metaphyseal cones, and increased levels of constraint, are also needed [3]. These measures, together with extensive soft-tissue exposure and dissection, increase the operative time of revision TKA compared with primary TKA. Our aim was to determine if revision TKA is amenable to a rapid recovery care pathway shown to effectively decrease the LOS, morbidity, and cost of primary TKA [[6], [7], [8]]. Application of a rapid recovery care pathway nonselectively to patients who underwent aseptic revision TKA resulted in an average LOS of 1.7 days, with 97% of patients being discharged home. On average, patients discharged on POD 1 were admitted for 22 hours, whereas patients discharged on POD 2 were admitted for 43 hours. This suggests POD 1 discharge may be possible regardless of the case start time, and POD 2 discharge may occur as a result of factors unrelated to the case start time. POD 1 discharge did not increase the likelihood of readmission or return to the ER after revision TKA in our study, or after primary TKA in multiple prior reports [7,10]. We did not find that patient characteristics or complexity of surgical reconstruction was predictive of the LOS after revision TKA. Bovonratwet et al found advanced age was a risk factor for increased LOS and readmission after primary TKA, although we did not find this to be the case in our patient cohort [11]. Per recent report, utilization of standardized care pathways better predicts primary TKA LOS than patient characteristics [12]. Primary TKA LOS is likely unaffected by complexity of surgical reconstruction. Sodhi et al. observed no increased LOS when primary TKA was performed with a hinged prosthesis compared with when it was performed with a less-constrained implant [13]. As a result, all patients should be considered as potential candidates for rapid recovery after aseptic revision TKA. Although this study may provide guidance in the management of patients who underwent revision TKA, we understand our work has limitations. First, our study is retrospective, so the quality of our conclusions is limited by the accuracy of available data. Second, our sample size may have resulted in type II error. However, the same factors that reduced our sample size, restrictive inclusion criteria and single-surgeon experience, also reduced data heterogeneity and confounding factors such as variable surgical technique. Third, our findings at an academic medical center may not be generalizable to other practice populations.

Conclusions

A rapid recovery care pathway used for aseptic revision TKA involving both femoral and tibial components allowed home discharge on POD 1 for the majority of patients. POD 1 discharge did not increase the likelihood of readmission or return to the ER. In applying the rapid recovery care pathway nonselectively to patients who underwent aseptic revision TKA at an academic medical center, we found neither patient characteristics nor complexity of surgical reconstruction affected LOS.

Conflict of interests

S. Nandi is a member of the editorial or governing board of the Journal of Arthroplasty and is a board or committee member of the AAHKS and AAOS, and M. Sahlani and J. Pontasch declare no potential conflicts of interest.
  13 in total

1.  Is Discharge Within a Day of Total Knee Arthroplasty Safe in the Octogenarian Population?

Authors:  Patawut Bovonratwet; Michael C Fu; Vineet Tyagi; Alex Gu; Peter K Sculco; Jonathan N Grauer
Journal:  J Arthroplasty       Date:  2018-10-11       Impact factor: 4.757

2.  Rapid Recovery After Total Joint Arthroplasty Using General Anesthesia.

Authors:  Jeffrey B Stambough; G Barnes Bloom; Paul K Edwards; Gregory R Mehaffey; C Lowry Barnes; Simon C Mears
Journal:  J Arthroplasty       Date:  2019-05-09       Impact factor: 4.757

3.  Venous Thromboembolic Events after Total Knee Arthroplasty: Which Patients Are at a High Risk?

Authors:  Wen-Li Dai; Ze-Ming Lin; Zhan-Jun Shi; Jian Wang
Journal:  J Knee Surg       Date:  2019-05-24       Impact factor: 2.757

4.  Operative Time, Length of Stay, Short-Term Readmission, and Complications after Hinged Primary Total Knee Arthroplasty: A Propensity Score Matched Analysis.

Authors:  Nipun Sodhi; Yatindra H Patel; Jaiben George; Assem A Sultan; Hiba K Anis; Jared M Newman; Thomas J Kryzak; Anton Khlopas; Joseph T Moskal; Michael A Mont
Journal:  J Knee Surg       Date:  2018-08-29       Impact factor: 2.757

5.  Discharge Destination After Total Joint Arthroplasty: An Analysis of Postdischarge Outcomes, Placement Risk Factors, and Recent Trends.

Authors:  Aakash Keswani; Michael C Tasi; Adam Fields; Andrew J Lovy; Calin S Moucha; Kevin J Bozic
Journal:  J Arthroplasty       Date:  2016-01-20       Impact factor: 4.757

6.  Rapid Recovery Total Joint Arthroplasty is Safe, Efficient, and Cost-Effective in the Veterans Administration Setting.

Authors:  John M Yanik; Nicholas A Bedard; Jessica M Hanley; Jesse E Otero; John J Callaghan; John L Marsh
Journal:  J Arthroplasty       Date:  2018-07-11       Impact factor: 4.757

7.  How Much Do Adverse Event Rates Differ Between Primary and Revision Total Joint Arthroplasty?

Authors:  Daniel D Bohl; Andre M Samuel; Bryce A Basques; Craig J Della Valle; Brett R Levine; Jonathan N Grauer
Journal:  J Arthroplasty       Date:  2015-09-28       Impact factor: 4.757

Review 8.  Enhanced recovery pathways in orthopedic surgery.

Authors:  Alan David Kaye; Richard D Urman; Elyse M Cornett; Brendon M Hart; Azem Chami; Julie A Gayle; Charles J Fox
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019-04

9.  Strategies for reducing implant costs in the revision total knee arthroplasty episode of care.

Authors:  Ameer M Elbuluk; Andrew B Old; Joseph A Bosco; Ran Schwarzkopf; Richard Iorio
Journal:  Arthroplast Today       Date:  2017-04-15

Review 10.  Consensus statement for perioperative care in total hip replacement and total knee replacement surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations.

Authors:  Thomas W Wainwright; Mike Gill; David A McDonald; Robert G Middleton; Mike Reed; Opinder Sahota; Piers Yates; Olle Ljungqvist
Journal:  Acta Orthop       Date:  2019-10-30       Impact factor: 3.717

View more
  1 in total

1.  Same-Day Discharge Following Aseptic Revision and Conversion Total Joint Arthroplasty: A Single-Institution Experience.

Authors:  Christopher F Deans; Leonard T Buller; Mary Ziemba-Davis; R Michael Meneghini
Journal:  Arthroplast Today       Date:  2022-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.